LINC00265/miR-4500 Axis Accelerates Acute Lymphoblastic Leukemia Progression by Enhancing STAT3 Signals

References

• Gavralidis A, Brunner AM. Novel therapies in the treatment of adult acute lymphoblastic leukemia. Curr Hematol Malig Rep. 2020. doi:10.1007/s11899-020-00591-4
   PubMed Web of Science ®Google Scholar
• Jabbour E, O’Brien S, Konopleva M, Kantarjian H. New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia. Cancer. 2015;121(15):2517–2528. doi:10.1002/cncr.2938325891003
   PubMed Web of Science ®Google Scholar
• Phelan KW, Advani AS. Novel therapies in acute lymphoblastic leukemia. Curr Hematol Malig Rep. 2018;13(4):289–299. doi:10.1007/s11899-018-0457-730078158
   PubMed Web of Science ®Google Scholar
• Short NJ, Kantarjian H, Jabbour E, Ravandi F. Novel therapies for older adults with acute lymphoblastic leukemia. Curr Hematol Malig Rep. 2018;119(2):91–99. doi:10.1002/jcb.26800
   Web of Science ®Google Scholar
• Hunger SP, Mullighan CG, Longo DL. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373(16):1541–1552. doi:10.1056/NEJMra140097226465987
   PubMed Web of Science ®Google Scholar
• Portell CA, Advani AS. Novel targeted therapies in acute lymphoblastic leukemia. Leuk Lymphoma. 2014;55(4):737–748. doi:10.3109/10428194.2013.82349323841506
   PubMed Web of Science ®Google Scholar
• Ng M, Heckl D, Klusmann J-H. The regulatory roles of long noncoding RNAs in acute myeloid leukemia. Front Oncol. 2019;9:570. doi:10.1038/s41408-019-0258-931338324
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun P, Zhao Y, Liu B. The role of Long Non-Coding RNAs (lncRNAs) and downstream signaling pathways in leukemia progression. Hematol Oncol. 2020. doi:10.1002/hon.2776
   Web of Science ®Google Scholar
• Zhang F, Li Q, Zhu K, et al. LncRNA LINC00265/miR-485-5p/IRF2-mediated autophagy suppresses apoptosis in acute myeloid leukemia cells. Am J Transl Res. 2020;12:2451–2462.32655783
   PubMed Web of Science ®Google Scholar
• Ma L, Kuai WX, Sun XZ, Lu XC, Yuan YF. Long noncoding RNA LINC00265 predicts the prognosis of acute myeloid leukemia patients and functions as a promoter by activating PI3K-AKT pathway. Eur Rev Med Pharmacol Sci. 2018;22:7867–7876. doi:10.26355/eurrev_201811_1641230536332
   PubMed Web of Science ®Google Scholar
• Romano G, Veneziano D, Acunzo M, Croce CM. Small non-coding RNA and cancer. Carcinogenesis. 2017;38(5):485–491. doi:10.1093/carcin/bgx02628449079
   PubMed Web of Science ®Google Scholar
• Almeida RS, Costa e Silva M, Coutinho LL, et al. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia. Hematol Oncol. 2019;37(1):103–112. doi:10.1002/hon.256730393877
   PubMed Web of Science ®Google Scholar
• Ghodousi ES, Rahgozar S. MicroRNA-326 and microRNA-200c: two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia. J Cell Biochem. 2018;119(7):6024–6032. doi:10.1002/jcb.2680029630744
   PubMed Web of Science ®Google Scholar
• Zang Y, Yu R, Bai Y, Chen X. MicroRNA-9 suppresses cancer proliferation and cell cycle progression in acute lymphoblastic leukemia with inverse association of neuropilin-1. J Cell Biochem. 2018;119(8):6604–6613. doi:10.1002/jcb.2679929693748
   PubMed Web of Science ®Google Scholar
• Jiang J, Liu Y, Zhao Y, Tian F, Wang G. miR-153-3p suppresses inhibitor of growth protein 2 expression to function as tumor suppressor in acute lymphoblastic leukemia. Technol Cancer Res Treat. 2019;18:1533033819852990. doi:10.1177/153303381985299031138034
   PubMed Web of Science ®Google Scholar
• Wang H, Guo Q, Zhu G, et al. microRNA-452 exerts growth-suppressive activity against T-cell acute lymphoblastic leukemia. J Investig Med. 2018;66(4):773–779. doi:10.1136/jim-2017-000591
   PubMed Web of Science ®Google Scholar
• Peng W, Dong N, Wu S, et al. miR-4500 suppresses cell proliferation and migration in bladder cancer via inhibition of STAT3/CCR7 pathway. J Cell Biochem. 2019. doi:10.1002/jcb.29558
   Web of Science ®Google Scholar
• Ge H, Yan Y, Yue C, Liang C, Wu J. Long noncoding RNA LINC00265 targets EGFR and promotes deterioration of colorectal cancer: a Comprehensive Study based on data mining and in vitro validation. Onco Targets Ther. 2019;12:10681–10692. doi:10.2147/OTT.S22748231824175
   PubMed Web of Science ®Google Scholar
• Li S, Mai H, Zhu Y, et al. MicroRNA-4500 inhibits migration, invasion, and angiogenesis of breast cancer cells via RRM2-dependent MAPK signaling pathway. Mol Ther Nucleic Acids. 2020;21:278–289. doi:10.1016/j.omtn.2020.04.01832615527
   PubMedGoogle Scholar
• Lee H, Jeong AJ, Ye S-K. Highlighted STAT3 as a potential drug target for cancer therapy. BMB Rep. 2019;52(7):415–423. doi:10.5483/BMBRep.2019.52.7.15231186087
   PubMed Web of Science ®Google Scholar
• Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genomics Proteomics Bioinformatics. 2016;14(1):42–54. doi:10.1016/j.gpb.2015.09.00626883671
   PubMed Web of Science ®Google Scholar
• James AR, Schroeder MP, Neumann M, et al. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia. J Hematol Oncol. 2019;12(1):8. doi:10.1186/s13045-018-0692-330642353
   PubMed Web of Science ®Google Scholar
• Liu X, Hao Y, Yu W, et al. Long non-coding RNA emergence during renal cell carcinoma tumorigenesis. Cell Physiol Biochem. 2018;47(2):735–746. doi:10.1159/00049002629794462
   PubMedGoogle Scholar
• Li M, Wang Y, Cheng L, et al. Long non-coding RNAs in renal cell carcinoma: a systematic review and clinical implications. Oncotarget. 2017;8(29):48424–48435. doi:10.18632/oncotarget.1705328467794
   PubMedGoogle Scholar
• Das Chagas PF, de Sousa GR, Kodama MH, et al. Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia. Hematol Transfus Cell Ther. 2020. doi:10.1016/j.htct.2019.12.003
   PubMedGoogle Scholar
• Cuadros M, Andrades Á, Coira IF, et al. Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemia. Blood Cancer J. 2019;9(12):93. doi:10.1038/s41408-019-0258-931767830
   PubMed Web of Science ®Google Scholar
• Frixa T, Donzelli S, Blandino G. Oncogenic MicroRNAs: key players in malignant transformation. Cancers. 2015;7(4):2466–2485. doi:10.3390/cancers704090426694467
   PubMed Web of Science ®Google Scholar
• Sun S, Li W, Ma X, Luan H. Long noncoding RNA LINC00265 promotes glycolysis and lactate production of colorectal cancer through regulating of miR-216b-5p/TRIM44 axis. Digestion. 2020;101(4):391–400. doi:10.1159/00050019531079111
   PubMed Web of Science ®Google Scholar
• Li S, Guo W, Geng H, Wang C, Yang S, Xu X. LINC00511 exacerbated T-cell acute lymphoblastic leukemia via miR-195-5p/LRRK1 axis. Biosci Rep. 2020;40(5). doi:10.1042/BSR20193631
   Web of Science ®Google Scholar
• Huang M, Zheng J, Ren Y, et al. LINC00221 suppresses the malignancy of children acute lymphoblastic leukemia. Biosci Rep. 2020;40(5). doi:10.1042/BSR20194070
   Web of Science ®Google Scholar
• Hughes K, Watson CJ. The multifaceted role of STAT3 in mammary gland involution and breast cancer. Int J Mol Sci. 2018;19(6):1695. doi:10.3390/ijms19061695
   PubMed Web of Science ®Google Scholar
• Geiger JL, Grandis JR, Bauman JE. The STAT3 pathway as a therapeutic target in head and neck cancer: barriers and innovations. Oral Oncol. 2016;56:84–92. doi:10.1016/j.oraloncology.2015.11.02226733183
   PubMed Web of Science ®Google Scholar